AU2001278436A1 - A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs - Google Patents

A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs

Info

Publication number
AU2001278436A1
AU2001278436A1 AU2001278436A AU7843601A AU2001278436A1 AU 2001278436 A1 AU2001278436 A1 AU 2001278436A1 AU 2001278436 A AU2001278436 A AU 2001278436A AU 7843601 A AU7843601 A AU 7843601A AU 2001278436 A1 AU2001278436 A1 AU 2001278436A1
Authority
AU
Australia
Prior art keywords
treatment
lateral sclerosis
amyotrophic lateral
mammalian organs
protein extractable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278436A
Inventor
Alberto Panerai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rakepoll Holding BV
Original Assignee
Rakepoll Holding BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding BV filed Critical Rakepoll Holding BV
Publication of AU2001278436A1 publication Critical patent/AU2001278436A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001278436A 2000-06-08 2001-06-04 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs Abandoned AU2001278436A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21000300P 2000-06-08 2000-06-08
US60/210,003 2000-06-08
PCT/EP2001/006336 WO2001093888A2 (en) 2000-06-08 2001-06-04 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
AU2001278436A1 true AU2001278436A1 (en) 2001-12-17

Family

ID=22781221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278436A Abandoned AU2001278436A1 (en) 2000-06-08 2001-06-04 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs

Country Status (7)

Country Link
US (1) US6855694B2 (en)
EP (1) EP1286683A2 (en)
JP (1) JP2003535139A (en)
AU (1) AU2001278436A1 (en)
CA (1) CA2411428A1 (en)
MX (1) MXPA02012091A (en)
WO (1) WO2001093888A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
DK0928197T3 (en) * 1996-09-18 2003-06-23 Zetesis Spa Use of proteins as agents for autoimmune diseases
IT1290828B1 (en) 1997-03-25 1998-12-11 Zetesis Spa USE OF EXTRACTABLE PROTEINS FROM ANIMAL ORGANS FOR THE PREPARATION OF MEDICATIONS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS

Also Published As

Publication number Publication date
CA2411428A1 (en) 2001-12-13
WO2001093888A2 (en) 2001-12-13
WO2001093888A3 (en) 2002-11-07
JP2003535139A (en) 2003-11-25
MXPA02012091A (en) 2004-08-19
US20030162705A1 (en) 2003-08-28
EP1286683A2 (en) 2003-03-05
US6855694B2 (en) 2005-02-15

Similar Documents

Publication Publication Date Title
AU2001282962A1 (en) Administering incentive award program
AU2002366644A1 (en) Method for administering birb 796 bs
AU2001246596A1 (en) Updating of subscriber information
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU2001252638A1 (en) Process for the preparation of 2-halobenzoic acids
AU6070400A (en) Process for the removal of mercaptans
AU4107501A (en) Method of anticipating interaction between proteins
AU2002246490A1 (en) Method of treating parkinson's disease
AU2001261519A1 (en) Methods of affecting laminin 5 processing
AU2002224555A1 (en) Process for producing recombinant protein
AU2002226999A1 (en) Process for permanent reshaping of hair
AU2001278436A1 (en) A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
AU2728901A (en) Method of making hydrofluorocarbons
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU2001244647A1 (en) Process for producing recombinant protein
AU2002303957A1 (en) Method of treating alzheimer's disease with se-containing peptide
AU2001279643A1 (en) A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
AU2001262177A1 (en) Method of treatment
AU2002222927A1 (en) Method of making hydrofluorocarbons
AU2001272453A1 (en) A method of treatment of huntington's chorea with a protein extractable from mammalian organs
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
AU2001262340A1 (en) A method of treatment of parkinson's disease with a protein extractable from mammalian organs
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine
AU2002221623A1 (en) Gene 4